An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

A twice-a-year injectable drug has been shown to be 100% effective in preventing the spread of HIV, according to the first data from a clinical trial. If approved, the drug offers another preventive ...

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option for HIV, offering patients a twice-yearly injection to reduce the risk of ...

March 4 (Reuters) - (This March 4 story has been corrected to remove a reference to declining revenue from current bestsellers in paragraph 3) GSK (GSK.L), opens new tab said on Monday a new ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found promise in permanently eliminating the virus, thanks to a drug already approved ...

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. A twice-yearly injection of a drug known as lenacapavir offered ...

A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths — agonizing, from diseases or infections the body might otherwise fight off — sent loved ones into the streets ...

A majority (91%) of HIV patients who received care through the Ryan White HIV/AIDS Program were virally suppressed in 2024, according to a new Health Resources and Services Administration (HRSA) ...